A carregar...
Fall of the mutants: T cells targeting BCR-ABL
Targeting the tumor-specific junction sequence produced by the BCR-ABL fusion has long been an attractive strategy and, in this issue of Blood, Comoli et al demonstrate, for the first time in humans, clinical benefit with infusions of (p190)BCR-ABL neoantigen-specific T cells to 3 patients with acti...
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5290991/ https://ncbi.nlm.nih.gov/pubmed/28153834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-12-757336 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|